Menopause

Top Research Topics at Menopause?

The journal was organized to reinforce research efforts on Internal medicine, Menopause, Endocrinology, Postmenopausal women and Gynecology. Internal medicine and Placebo are closely related fields of research discussed in it. The research on Menopause tackled can also make contributions to studies in the areas of Gerontology, MEDLINE, Cross-sectional study, Obstetrics and Physical therapy.

Studies on Endocrinology discussed in the journal link to the field of Physiology. It addresses concerns in Randomized controlled trial which are intertwined with other disciplines, such as Vasomotor, Clinical trial and Quality of life. Hormone therapy studies tackled cover an aspect of the field of Breast cancer.

Bone mineral studies covered in it falls within the purview of Osteoporosis. The journal features studies on Osteoporosis, including topics such as Bone density.

• Internal medicine (40.47%)
• Menopause (32.44%)
• Endocrinology (22.80%)

What are the most cited papers published in the journal?

• The 2017 hormone therapy position statement of The North American Menopause Society. (541 citations)
• The 2012 hormone therapy position statement of the North American Menopause Society (535 citations)
• Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. (510 citations)

Research areas of the most cited articles at Menopause:

The journal papers tackle a plethora of topics, such as Menopause, Internal medicine, Endocrinology, Gynecology and Randomized controlled trial. Body mass index, Physical therapy, Gerontology, Hormone therapy and Vasomotor are some topics wherein Menopause research discussed in the most cited publications has an impact. The studies tackled in the journal articles, which mainly focus on Internal medicine, apply to Placebo as well.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Diabetes mellitus

The previous edition focused in particular on these issues:

The journal aims to foster the development of research in Menopause, Internal medicine, MEDLINE, Obstetrics and Body mass index. While the primary focus in it is Menopause, it also dissects topics surrounding Hormone therapy and Hormone as a whole. It focuses on Internal medicine but the discussions also offer insight into other areas such as Placebo, Endocrinology and Cardiology.

Aside from discussions in MEDLINE, Menopause also deals with the subject of Intensive care medicine which intersects with Quality of life (healthcare) disciplines. The study of Logistic regression and how it intertwines with concepts under Cross-sectional study were explored in the presented Odds ratio research. Topics in Randomized controlled trial explored in it were investigated in conjunction with research in Meta-analysis, Physical therapy and Clinical trial.

The most cited articles from the last journal are:

• Biopsychosocial predictors of depressive symptoms in the perimenopause-findings from the Swiss Perimenopause Study. (5 citations)
• Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets. (5 citations)
• Prevalence of symptoms and associated factors across menopause status in Taiwanese women. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Menopause (based on the number of publications) are:

• JoAnn E. Manson (81 papers) published 4 papers at the last edition, 7 less than at the previous edition,
• Nancy Fugate Woods (68 papers) published 2 papers at the last edition the same number as at the previous edition,
• Sybil L. Crawford (63 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• David F. Archer (56 papers) published 2 papers at the last edition the same number as at the previous edition,
• Susan R. Davis (54 papers) published 2 papers at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Menopause (based on the number of publications) are:

• Harvard University (149 papers) published 10 papers at the last edition, 1 less than at the previous edition,
• University of Washington (122 papers) published 5 papers at the last edition, 2 less than at the previous edition,
• University of Pittsburgh (118 papers) published 11 papers at the last edition the same number as at the previous edition,
• University of California, San Diego (77 papers) published 5 papers at the last edition, 5 less than at the previous edition,
• Mayo Clinic (77 papers) published 10 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.03% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.35% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.74% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.51% of all publications and 54.40% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Pathways in Menopausal Research

One major area that the article could touch on is the career opportunities and pathways that exist within the field of Menopausal Research. There are numerous routes through which one might journey in this particular field, with a career in nursing being one of the most lucrative. For instance, if you opt to specialize in women's health or gerontology as a nurse, dealing with menopausal issues would be an integral part of your job. From being a nurse practitioner in a gynecological clinic, to research nursing in a biomedical lab focusing on hormone therapy, the options are endless. Moreover, understanding menopausal issues not only helps medical professionals to offer the essential care and support for women undergoing menopause but also opens avenues to be part of groundbreaking research that could improve women's quality of life. For those interested in this area, consider starting the journey by visiting this comprehensive guide on {anchor}. Other than nursing, opportunities also exist in research and academia, pharmaceutical sciences, and more. Remember, each profession within the menopausal research avenue contributes to a better understanding of menopause as a crucial phase in women’s lives, and in doing so, it helps to improve the overall health and well-being of postmenopausal women.